135 related articles for article (PubMed ID: 17622936)
1. Discovery and characterization of a cytochrome b5 variant in humans with impaired hydroxylamine reduction capacity.
Kurian JR; Longlais BJ; Trepanier LA
Pharmacogenet Genomics; 2007 Aug; 17(8):597-603. PubMed ID: 17622936
[TBL] [Abstract][Full Text] [Related]
2. NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans.
Kurian JR; Bajad SU; Miller JL; Chin NA; Trepanier LA
J Pharmacol Exp Ther; 2004 Dec; 311(3):1171-8. PubMed ID: 15302896
[TBL] [Abstract][Full Text] [Related]
3. Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.
Kurian JR; Chin NA; Longlais BJ; Hayes KL; Trepanier LA
Chem Res Toxicol; 2006 Oct; 19(10):1366-73. PubMed ID: 17040106
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of the reduction of cytochrome b5 with mutations in its membrane-binding domain.
Wu FF; Vergères G; Waskell L
Arch Biochem Biophys; 1994 Feb; 308(2):380-6. PubMed ID: 7906503
[TBL] [Abstract][Full Text] [Related]
5. Expression of lipase-solubilized bovine liver microsomal cytochrome b5 in Escherichia coli as a glutathione S-transferase fusion protein (GST-cyt b5).
Lin YW; Zhao DX; Wang ZH; Yu WH; Huang ZX
Protein Expr Purif; 2006 Feb; 45(2):352-8. PubMed ID: 16146697
[TBL] [Abstract][Full Text] [Related]
6. Role of carboxyl residues surrounding heme of human cytochrome b5 in the electrostatic interaction with NADH-cytochrome b5 reductase.
Kawano M; Shirabe K; Nagai T; Takeshita M
Biochem Biophys Res Commun; 1998 Apr; 245(3):666-9. PubMed ID: 9588172
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.
Sacco JC; Trepanier LA
Pharmacogenet Genomics; 2010 Jan; 20(1):26-37. PubMed ID: 19997042
[TBL] [Abstract][Full Text] [Related]
8. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
[TBL] [Abstract][Full Text] [Related]
9. Heterologous expression and mechanistic investigation of a fungal cytochrome P450 (CYP5150A2): involvement of alternative redox partners.
Ichinose H; Wariishi H
Arch Biochem Biophys; 2012 Feb; 518(1):8-15. PubMed ID: 22206618
[TBL] [Abstract][Full Text] [Related]
10. Preparation of apo-cytochrome b5 utilizing heme transfer to apo-myoglobin.
Mrazova B; Martinek V; Martinkova M; Sulc M; Frei E; Stiborova M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():72-9. PubMed ID: 20027148
[TBL] [Abstract][Full Text] [Related]
11. P450 redox enzymes in the white rot fungus Phanerochaete chrysosporium: gene transcription, heterologous expression, and activity analysis on the purified proteins.
Subramanian V; Doddapaneni H; Syed K; Yadav JS
Curr Microbiol; 2010 Oct; 61(4):306-14. PubMed ID: 20221604
[TBL] [Abstract][Full Text] [Related]
12. The influence of mutation at Glu44 and Glu56 of cytochrome b5 on the protein's stabilization and interaction between cytochrome c and cytochrome b5.
Qian W; Sun YL; Wang YH; Zhuang JH; Xie Y; Huang ZX
Biochemistry; 1998 Oct; 37(40):14137-50. PubMed ID: 9760250
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome b5 oxidoreductase: expression and characterization of the original familial ideopathic methemoglobinemia mutations E255- and G291D.
Davis CA; Barber MJ
Arch Biochem Biophys; 2004 May; 425(2):123-32. PubMed ID: 15111120
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of a functional canine variant of cytochrome b5 reductase.
Roma GW; Crowley LJ; Barber MJ
Arch Biochem Biophys; 2006 Aug; 452(1):69-82. PubMed ID: 16814740
[TBL] [Abstract][Full Text] [Related]
15. Expression of functionally active cytochrome b5 in Escherichia coli: isolation, purification, and use of the immobilized recombinant heme protein for affinity chromatography of electron-transfer proteins.
Chudaev MV; Usanov SA
Biochemistry (Mosc); 1997 Apr; 62(4):401-11. PubMed ID: 9275279
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of Glycine 179 modulates both catalytic efficiency and reduced pyridine nucleotide specificity in cytochrome b5 reductase.
Roma GW; Crowley LJ; Davis CA; Barber MJ
Biochemistry; 2005 Oct; 44(41):13467-76. PubMed ID: 16216070
[TBL] [Abstract][Full Text] [Related]
17. Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast.
Rhoads K; Sacco JC; Drescher N; Wong A; Trepanier LA
Toxicol Sci; 2011 Jun; 121(2):245-56. PubMed ID: 21447608
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a novel splice variant of mouse and rat cytochrome b5/cytochrome b5 reductase.
Curry BJ; Roman SD; Wallace CA; Scott R; Miriami E; Aitken RJ
Genomics; 2004 Mar; 83(3):425-38. PubMed ID: 14962668
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of human cytochrome b5 increases expression of cytochrome P450 3A4 in Escherichia coli by stabilizing mRNA.
Dong MS; Lee SB; Kim HJ
Protein Expr Purif; 2013 May; 89(1):44-50. PubMed ID: 23459292
[TBL] [Abstract][Full Text] [Related]
20. Effect of Cytochrome b5 Content on the Activity of Polymorphic CYP1A2, 2B6, and 2E1 in Human Liver Microsomes.
Zhang H; Gao N; Liu T; Fang Y; Qi B; Wen Q; Zhou J; Jia L; Qiao H
PLoS One; 2015; 10(6):e0128547. PubMed ID: 26046844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
